|
Volumn 37, Issue 2, 2005, Pages 170-174
|
Reduction in vertebral fracture risk in teriparatide-treated postmenopausal women as assessed by spinal deformity index
|
Author keywords
Back pain; Fracture risk; Height loss; Osteoporosis; Postmenopausal women; Spinal deformity index; Teriparatide
|
Indexed keywords
PARATHYROID HORMONE[1-34];
PLACEBO;
ADULT;
AGED;
ARTICLE;
BACKACHE;
BODY HEIGHT;
BONE RADIOGRAPHY;
CALCULATION;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DIAGNOSTIC PROCEDURE;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HUMAN;
MAJOR CLINICAL STUDY;
MENOPAUSAL SYNDROME;
MULTICENTER STUDY;
OSTEOPOROSIS;
QUANTITATIVE ANALYSIS;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SELF INJECTION;
SPINAL DEFORMITY INDEX;
VERTEBRA FRACTURE;
AGED;
BONE DENSITY CONSERVATION AGENTS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MIDDLE AGED;
OSTEOPOROSIS, POSTMENOPAUSAL;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
SEVERITY OF ILLNESS INDEX;
SPINAL FRACTURES;
TERIPARATIDE;
|
EID: 21844445305
PISSN: 87563282
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bone.2005.04.023 Document Type: Article |
Times cited : (25)
|
References (13)
|